What early knee OA actually feels like

Something feels slightly off with the knee — a faint grinding sensation when climbing stairs, a stiffness that takes a few minutes to ease after sitting, a dull ache along the joint line after a long walk that disappears by morning. Most people file this away as overuse, a bad week, or simply getting older. That instinct to normalise is exactly why early knee osteoarthritis is so often missed.

The early symptom cluster tends to be quiet rather than dramatic. Crepitus — the clicking or crunching felt during movement — is frequently painless at this stage, so it rarely prompts concern. Any loss of range of motion tends to be gradual enough that patients adapt their movement patterns without consciously registering the change. Tenderness along the joint line is often intermittent, appearing after activity and then fading, which makes it easy to dismiss as muscular rather than joint-related.

This is not what most people picture when they hear the word 'arthritis.' The popular image — a severely swollen, constantly painful joint — belongs to a much later stage of the disease. By the time constant pain appears at rest, or pain begins waking someone at night, the structural changes within the joint have typically advanced significantly and become far harder to reverse.

The practical difficulty is that early OA symptoms overlap with other common presentations: post-exercise muscle soreness, patellofemoral pain, and minor meniscal irritation can all feel similar on a day-to-day basis. Symptom-watching alone is rarely enough to distinguish them. Careful clinical assessment — and in many cases imaging — is what separates a pattern worth investigating from something that will resolve on its own.

Why a normal X-ray does not rule out early OA

A 'clear' knee X-ray is genuinely reassuring in some scenarios — but it cannot rule out early osteoarthritis. The reason lies in how the most widely used diagnostic criteria for knee OA were written.

The American College of Rheumatology classification, published in 1986 and still in common clinical use, requires positive findings such as osteophytes (bony outgrowths), measurable joint space narrowing, or age over 50. These are features of established disease. By definition, a patient whose cartilage is already degrading but has not yet reached that structural threshold will appear to meet no formal OA criteria — even when more sensitive imaging would tell a different story.

The 2014 First International Early Knee OA Workshop in Tokyo addressed this gap directly, producing consensus classification criteria spanning three domains: patient-reported symptoms, functional status, and structural findings detected either arthroscopically or on MRI. Under these criteria, meaningful early changes qualify — not just those visible on plain X-ray.

MRI is considerably more sensitive for this purpose. The 2014 structural thresholds require at least two of the following: cartilage damage reaching a specific depth and area (assessed using scoring scales called WORMS and BLOKS, which rate cartilage loss across defined knee regions from mild surface softening through to substantial regional loss of up to 75%), meniscal tears above a certain severity grade, or bone marrow lesions. All of these can be present well before joint space narrowing appears on an X-ray.

More advanced still, compositional MRI techniques — including T2 mapping, dGEMRIC, and T1ρ imaging — detect changes in the biochemical make-up of cartilage tissue before any structural loss is visible at all, offering a genuine pre-symptomatic detection window that conventional imaging cannot provide.

Structural findings on MRI are, however, one input into a broader clinical picture. Imaging changes alone are not a diagnosis; a consultant weighs them alongside symptom history, functional assessment, and physical examination before drawing conclusions about what is actually happening in the joint.

How OA progresses — and where the early phase sits

Cartilage has no meaningful blood supply and limited capacity for self-repair. Once significant morphological loss has occurred, the tissue does not regenerate on its own — which makes the period before that threshold is crossed structurally distinct from any later stage of the disease. It is not simply that intervention is harder later; it is that the tissue being protected no longer exists.

Biomechanical contributors make that window time-sensitive. Muscle weakness and joint instability alter how load is distributed across knee compartments — a mechanism explored in more detail in the next section — but the important point here is that these factors are modifiable. Intervening early means addressing causes, not just managing consequences.

A specific event can mark when the early window opens. Around 12% of advanced knee OA has its origins in joint trauma — a clinically identifiable trigger from which a post-traumatic trajectory begins. For these patients, the start of the early phase is often not hidden or gradual: it is datable, which matters for both monitoring and treatment timing.

Population figures illustrate how widely that window is currently being missed. Applying the 2014 Tokyo classification criteria to the general population, Sasaki et al. found early knee OA in 9.5% of males and 15.0% of females — prevalence rates far higher than clinical consultation figures would suggest. Most people in the early phase are not presenting for care and are therefore not receiving it.

OA is estimated to affect 240 million people globally and ranks fourth worldwide as a cause of disability. Much of that burden reflects disease that progressed, unchecked, through an early phase when structural deterioration was still limited and the modifiable factors driving it remained addressable.

Modifiable risk factors in the early phase

Several of the factors that accelerate early-stage knee OA are modifiable — which makes identifying them clinically useful rather than simply descriptive.

• Quadriceps weakness. The quadriceps absorb a substantial share of the compressive force passing through the knee during walking and stair-climbing. When they are weak, that load falls more heavily on cartilage and supporting structures. Strength-focused rehabilitation directly targets this mechanism rather than working around it.
• Excess body weight. Every additional kilogram of body weight amplifies the compressive load through the knee joint with each step. Evidence suggests even modest reductions in body weight produce measurable improvements in knee pain and function — placing weight management firmly in the early-phase treatment frame, not as an afterthought.
• Lower-limb malalignment. A varus ('bow-legged') or valgus ('knock-kneed') alignment shifts load preferentially into one compartment of the knee, concentrating wear in that region. Clinical assessment can establish whether bracing, orthotics, or further alignment correction is appropriate.
• Prior joint injury. Patients with a history of ligament tears, significant meniscal damage, or intra-articular fractures carry a recognised risk of OA following a post-traumatic route. For this group, proactive monitoring — rather than a passive 'wait and see' approach — is the more appropriate response to that history.

Taken together, these are not just background characteristics: they are levers. Addressing them during the early phase means intervening in what is driving disease progression, not simply managing the discomfort it produces.

Conservative care during the early phase

The starting point for most patients in the early phase is the same: structured, supervised exercise. OARSI 2019 guidelines (Bannuru et al., Osteoarthritis and Cartilage) provide graded recommendations for exercise, weight management, and analgesia as first-line non-surgical management — not as provisional measures to try before 'real' treatment, but as the primary therapeutic pathway.

Physical therapy carries more weight in that evidence base than is sometimes assumed. A 2020 trial published in the New England Journal of Medicine (Deyle et al.) compared structured physical therapy directly with glucocorticoid injection and found comparable functional outcomes — positioning physiotherapy as a substantive intervention in its own right, not simply an adjunct. Addressing quadriceps weakness and neuromuscular control through targeted rehabilitation is mechanistically relevant for the reasons covered in the preceding section: it reduces the abnormal loading that is driving early damage.

Non-operative management is the appropriate starting point whenever significant contraindications to conservative care are absent. Surgery carries no guarantee of return to prior function and is not a first-line step; for early-stage disease in particular, the risk-benefit arithmetic strongly favours the conservative route first.

For patients with confirmed early-to-moderate OA who have not achieved adequate improvement through exercise and physiotherapy alone, the conservative continuum can extend to intra-articular options — hyaluronic acid, PRP, and newer biologics — positioned as escalation within conservative care rather than a move toward surgical territory.

The ceiling of that continuum is worth naming clearly: current evidence is stronger for symptomatic improvement than for demonstrating that early conservative intervention alters the rate of structural cartilage loss over time — a distinction patients should understand when weighing their options.

When to seek specialist assessment

Deciding whether to escalate beyond GP-level care is often the question patients find hardest to answer. A reasonable rule of thumb: if symptoms have persisted for six to eight weeks despite initial self-management — or if function is worsening rather than plateauing — a specialist review is justified rather than optional.

Some clinical histories warrant earlier input. A prior ACL tear, significant meniscal injury, or intra-articular fracture puts a patient on the post-traumatic OA pathway described earlier in this article; monitoring should be proactive rather than reactive in those cases.

On imaging: if a plain X-ray has already been reported as normal but symptoms are continuing, that result does not close the diagnostic question. MRI — including compositional techniques such as T2 mapping or T1ρ where available — is the more appropriate investigation when early structural change is suspected, and it is worth asking a GP specifically whether onward referral for MRI is warranted.

What specialist assessment adds at this stage is clarification, not necessarily a treatment plan. Staging the OA accurately, ruling out other causes of knee pain, and sequencing care appropriately are the practical outputs of that consultation. In the early phase, the goal of specialist involvement is joint preservation — not surgical planning.

1. [1] Osteoarthritis — NHS. https://www.nhs.uk/conditions/osteoarthritis/ https://www.nhs.uk/conditions/osteoarthritis/
2. [2] Osteoarthritis — Wikipedia. https://en.wikipedia.org/?curid=504841 https://en.wikipedia.org/?curid=504841